GEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Synageva BioPharma Corp's account receivable for the three months ended in Sep. 2014 was $1.36 Mil. Synageva BioPharma Corp's revenue for the three months ended in Sep. 2014 was $1.33 Mil. Hence, Synageva BioPharma Corp's days sales outstanding for the three months ended in Sep. 2014 was 93.73.
Synageva BioPharma Corp's days sales outstanding increased from Sep. 2013 (76.12) to Sep. 2014 (93.73).
Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Account receivable can be measured by Days Sales Outstanding.
Synageva BioPharma Corp's Days Sales Outstanding for the fiscal year that ended in Dec. 2013 is calculated as
Synageva BioPharma Corp's Days Sales Outstanding for the quarter that ended in Sep. 2014 is calculated as:
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Synageva BioPharma Corp Annual Data
Synageva BioPharma Corp Quarterly Data